Stay abreast of COVID-19 information and developments here
Provided by the South African National Department of Health
NETCARE: THE WOUNDS
ARE HEALING
South African-listed private hospital groups have significantly underperformed the JSE over the past decade. While there are some positive signs for the industry, the operating landscape remains difficult and the near-term growth outlook is uninspiring. Hospitals nonetheless are still highly cash-generative businesses able to return most of their earnings to shareholders. We hold Netcare in our client portfolios and despite the known challenges facing the sector, we see ample margin of safety for the company from its current share price levels.
At the end of 2015, hospital groups were among the darlings in investment portfolios, having outperformed the market by several multiples over the prior 15 years, as the private medical market grew rapidly over the period. From 2000 to 2015, a R1 million investment in Netcare would have yielded just over R50 million compared to R10 million from a similar investment in the JSE All Share Index (30% per annum compared to 16% for the market, all dividends reinvested).
Fast-forward almost 10 years from 2015 to the end of June 2024 and this R50 million would have become R26 million (-8% per annum), while the R10 million in the market would have grown to R21 million (9% per annum).
The reasons for the poor performance over the past decade stem primarily from a stagnant medical aid pool as the South African economy failed to expand its formal sector employment levels over the period. In fact, the number of medical scheme members – nine million – has remained virtually unchanged over the past 10 years. The resultant oversupply of hospital beds has given the schemes more pricing power and the ability to negotiate network deals at far below market levels.
In addition, the hospital cost base has been under pressure due to insufficient numbers of new nurses being trained by government facilities, which has led to a severe shortage and thus more negotiating power for workers when wages are set. To compound matters further, the Covid-19 pandemic had a short-term negative impact on hospital demand. These factors have worked in unison to squeeze both hospital margins and returns on capital.
Clearly, this is not a sustainable situation, and it can’t go on indefinitely – either demand for private healthcare needs to pick up or supply must be rationalised. The problem with the latter option is that the capital has already been spent, so it often makes more sense to continue to operate for as long as the hospital can still break even after paying staff. The more likely outcome is that few new hospitals will be built until demand can catch up and existing hospitals see better occupancy rates.
What are the prospects for growth in private hospital demand? This will depend to a large extent on economic growth in South Africa. While the recent formation of the government of national unity was viewed in a positive light by the market, many challenges remain. However, with the threat of the political far left removed for now, as well as increased accountability in the government, the outcome of the elections was certainly net positive.
In terms of economic growth, there is also low-hanging fruit. The Bureau for Economic Research estimates that if only the structural reforms currently in progress (for example, rail and electricity) are completed, gross domestic product growth can lift from ~1% currently to closer to 3.5%. If this growth is sustained, it can make a meaningful difference to employment as well as to medical aid membership.
An additional supportive trend for hospitals is the ageing medical aid population. Although scheme membership is not growing, the existing pool is expected to use more healthcare services over time as they age.
No discussion about private healthcare can be complete without considering National Health Insurance (NHI). Despite objections by numerous parties, NHI was recently signed into law by President Cyril Ramaphosa. The NHI document proposes a system that will eventually see no medical schemes, with a single buyer of healthcare services from either private or public facilities for all citizens. While this doesn’t necessarily have to be detrimental to private hospitals, since it will probably result in higher patient volumes, the pricing power of a single buyer is likely to eventually lead to a net negative outcome.
While we are cognisant of the risks of NHI to our investment case for Netcare, we still believe that not much is likely to change for at least the next decade. NHI faces severe funding constraints, not to mention legal pushback against many of its clauses, including those setting out where medical professionals should work and disallowing private medical schemes entirely for services already covered by NHI. In addition, the initial focus will be on clinics and primary healthcare, which won’t impact private hospitals directly. The most significant short-term impact may be the loss of medical practitioners to emigration because of future uncertainties.
How has Netcare responded to the market challenges? After the company’s exit from the UK in 2018, the focus has been on optimising the existing asset base and increasing efficiency. We think Netcare has done well in highly challenging operating conditions. The company recently concluded its digitisation programme, in terms of which health records are now electronic, eliminating some costs and improving customer experience. Unlike its largest listed peer, Life Healthcare, Netcare took a much harder stance on network options, settling for a lower occupancy rate rather than accepting uneconomic tariffs on new network deals. Time will tell which strategy works best.
Despite the poor market conditions, the valuation is appealing in the context of a highly cash-generative business. Earnings essentially equal free cash flow given limited capital spend on new facilities (except for some growth in mental health facilities – unfortunately a growing problem in our society). Based on our estimates, without assuming any meaningful growth in patient visits, the current market cap can be repaid by dividends or buybacks in roughly seven years, with the business trading on a forward free cash flow yield of more than 10%. By another measure, we estimate that the hospital groups have market values worth only 50% of the replacement cost of their entire hospital portfolios.
Therefore, looking forward, we see a favourable risk-reward trade-off from current price levels. While private hospitals may not be the most exciting growth story, in our view, Netcare’s cash underpin, combined with the low valuation, provides ample margin of safety.
Sanlam Private Wealth manages a comprehensive range of multi-asset (balanced) and equity portfolios across different risk categories.
Our team of world-class professionals can design a personalised offshore investment strategy to help diversify your portfolio.
Our customised Shariah portfolios combine our investment expertise with the wisdom of an independent Shariah board comprising senior Ulama.
We collaborate with third-party providers to offer collective investments, private equity, hedge funds and structured products.
Your wealth plan is designed with you in mind. Your financial reality, aspirations and risk profile.
Carl Schoeman has spent 22 years in Investment Management.
Have a question for Carl?
South Africa
South Africa Home Sanlam Investments Sanlam Private Wealth Glacier by Sanlam Sanlam BlueStarRest of Africa
Sanlam Namibia Sanlam Mozambique Sanlam Tanzania Sanlam Uganda Sanlam Swaziland Sanlam Kenya Sanlam Zambia Sanlam Private Wealth MauritiusGlobal
Global Investment SolutionsCopyright 2019 | All Rights Reserved by Sanlam Private Wealth | Terms of Use | Privacy Policy | Financial Advisory and Intermediary Services Act (FAIS) | Principles and Practices of Financial Management (PPFM). | Promotion of Access to Information Act (PAIA) | Conflicts of Interest Policy | Privacy Statement
Sanlam Private Wealth (Pty) Ltd, registration number 2000/023234/07, is a licensed Financial Services Provider (FSP 37473), a registered Credit Provider (NCRCP1867) and a member of the Johannesburg Stock Exchange (‘SPW’).
MANDATORY DISCLOSURE
All reasonable steps have been taken to ensure that the information on this website is accurate. The information does not constitute financial advice as contemplated in terms of FAIS. Professional financial advice should always be sought before making an investment decision.
INVESTMENT PORTFOLIOS
Participation in Sanlam Private Wealth Portfolios is a medium to long-term investment. The value of portfolios is subject to fluctuation and past performance is not a guide to future performance. Calculations are based on a lump sum investment with gross income reinvested on the ex-dividend date. The net of fee calculation assumes a 1.15% annual management charge and total trading costs of 1% (both inclusive of VAT) on the actual portfolio turnover. Actual investment performance will differ based on the fees applicable, the actual investment date and the date of reinvestment of income. A schedule of fees and maximum commissions is available upon request.
COLLECTIVE INVESTMENT SCHEMES
The Sanlam Group is a full member of the Association for Savings and Investment SA. Collective investment schemes are generally medium to long-term investments. Past performance is not a guide to future performance, and the value of investments / units / unit trusts may go down as well as up. A schedule of fees and charges and maximum commissions is available on request from the manager, Sanlam Collective Investments (RF) Pty Ltd, a registered and approved manager in collective investment schemes in securities (‘Manager’).
Collective investments are traded at ruling prices and can engage in borrowing and scrip lending. The manager does not provide any guarantee either with respect to the capital or the return of a portfolio. Collective investments are calculated on a net asset value basis, which is the total market value of all assets in a portfolio including any income accruals and less any deductible expenses such as audit fees, brokerage and service fees. Actual investment performance of a portfolio and an investor will differ depending on the initial fees applicable, the actual investment date, date of reinvestment of income and dividend withholding tax. Forward pricing is used.
The performance of portfolios depend on the underlying assets and variable market factors. Performance is based on NAV to NAV calculations with income reinvestments done on the ex-dividend date. Portfolios may invest in other unit trusts which levy their own fees and may result is a higher fee structure for Sanlam Private Wealth’s portfolios.
All portfolio options presented are approved collective investment schemes in terms of Collective Investment Schemes Control Act, No. 45 of 2002. Funds may from time to time invest in foreign countries and may have risks regarding liquidity, the repatriation of funds, political and macroeconomic situations, foreign exchange, tax, settlement, and the availability of information. The manager may close any portfolio to new investors in order to ensure efficient management according to applicable mandates.
The management of portfolios may be outsourced to financial services providers authorised in terms of FAIS.
TREATING CUSTOMERS FAIRLY (TCF)
As a business, Sanlam Private Wealth is committed to the principles of TCF, practicing a specific business philosophy that is based on client-centricity and treating customers fairly. Clients can be confident that TCF is central to what Sanlam Private Wealth does and can be reassured that Sanlam Private Wealth has a holistic wealth management product offering that is tailored to clients’ needs, and service that is of a professional standard.